Article Information
History
- October 25, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anthony Matthews, research fellow1,2,3,†,
- Sharon Peacock Hinton, research associate2,
- Susannah Stanway, consultant in medical oncology4,
- Alexander R Lyon, clinical senior lecturer5,6,3,
- professor Liam Smeeth1,
- Jennifer L. Lund, assistant professor2,* and
- professor Krishnan Bhaskaran1,*
- 1Department of Non-Communicable Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
- 2Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
- 3Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
- 4Royal Marsden Hospital, London, SW3 6JJ, UK
- 5National Heart and Lung Institute, Imperial College London, London, SW3 6LY, UK
- 6Royal Brompton Hospital, London, SW3 6NP, UK
- ↵†Corresponding author:
Anthony Matthews: Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden; anthony.matthews{at}ki.se; +4670 2186973
↵* Equal contribution
Posted October 25, 2019.
Endocrine therapy use and the risk of cardiovascular disease in postmenopausal breast cancer survivors: two cohort studies in the UK and US
